Plenary Lecture I

Wednesday, February 13: 9:00-9:45 am

Muckle.jpg

Environmental contaminants and Inuit child development: 25 years of interdisciplinary research
Presenter: Gina Muckle (Laval University) 

After postdoctoral fellowships in developmental psychology and in environmental health, Dr. Muckle was professor at the Department of Social and Preventive Medicine at UL for five years before being hired at the School of Psychology in 2003. Her area of specialization, developmental and behavioral teratology, integrates concepts from child development, toxicology and epidemiology. Her research focus on developmental effects of pre- and postnatal exposure to environmental contaminants such as pesticides and heavy metals. This work brought her to work with highly exposed populations like the Inuit of northern Canada. Her work based on a cohort of Inuit children followed from pregnancy to adolescence helped shed light on the developmental effects of mercury, lead and PCB exposure. Dr. Muckle is also co-principal investigator of the Canadian MIREC mother-child cohort providing data on effects of low exposure to environmental chemicals. Results of her work and are used by Canada to support the signing of the Minamata Convention on mercury. She has received research grants from CIHR, FRQS, NIH, Indian Affairs and Northern Development and Health Canada. She has been a member one CIHR Institute advisory committee and the Canadian Government Chemicals Management Plan Challenge Advisory Panel.

(Sponsored by CIHR)


Plenary Lecture II

Thursday, February 14: 9:00-9:45 am

Inder.jpg


Insights into the Encephalopathy of Prematurity - Pathways and Consequences
Presenter: Terrie Inder (Brigham and Women's Hospital)

I am a dual boarded child neurologist and neonatologist who undertakes clinical and translational research into the nature and timing of brain injury and alterations in brain development using magnetic resonance imaging (MRI) techniques. I have undertaken longitudinal studies in three large cohorts of high risk infants that have been followed up to adolescence to examine the relationship of alterations in brain structure to developmental outcomes. My laboratory aims to undertake clinical investigations of treatments and preventive strategies that may improve outcomes in high risk infants.  We also strive to have a means of accurate, early diagnosis of brain injury or altered brain development. I have published over 200 peer-reviewed scientific papers. Alongside this focused research effort, I have acquired leadership skills in neuroscience research and academic activities, including mentorship. I was recruited to Brigham and Women’s Hospital in 2013 as Chair of new Department of Pediatric Newborn Medicine.

(Sponsored by Kids Brain Health Network and Canadian Neonatal Brain Platform)


Plenary Lecture III

Thursday, February 14: 3:15-4:00 pm

roseboom.png


Hyperemesis gravidarum - how little we know about etiology, treatment and long term consequences for mother and offspring
Presenter: Tessa Roseboom (University of Amsterdam)

Tessa Roseboom is a Professor of Early Development and Health at the Academic Medical Centre in Amsterdam, the Netherlands. Her work focuses on the impact of the early life environment on growth, development and health throughout life. Her studies in the Dutch famine birth cohort provided the first direct evidence in humans that maternal nutrition during gestation affected offspring´s and potentially grand-offspring’s health (www.hongerwinter.nl). Her current research focuses on the fundamental biological processes that underlie ‘developmental programming’ and on translation to current pregnancies, in developed and developing settings. These studies include observational and experimental studies of the long-term consequences of lifestyle interventions before and during pregnancy (www.womb-project.eu), obstetric interventions, hyperemesis gravidarum, and assisted reproduction techniques. The ultimate aim of her work is to contribute to improved human health by giving each child the best possible start in life.

(Sponsored by Molly Towell Perinatal Research Foundation)


Plenary Lecture IV

Friday, February 15: 9:00-9:45am

ART and Clinical Outcomes (Methapharm)
Presenter: Cliff Librach (CReATe Fertility Centre)